These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4346549)

  • 21. Allylisopropylacetamide-induced propyria-protective effect of 3,5-dimethylisooxazole.
    Pinelli A; Favalli L
    Biochem Pharmacol; 1973 Apr; 22(7):797-801. PubMed ID: 4692646
    [No Abstract]   [Full Text] [Related]  

  • 22. Porphyric diseases in man.
    Levere RD; Pindyck J
    Ann Clin Lab Sci (1971); 1971; 1(2):101-12. PubMed ID: 4949571
    [No Abstract]   [Full Text] [Related]  

  • 23. Decreased levels of cytochrome P-450 and catalase in hepatic porphyria caused by substituted acetamides and barbiturates. Importance of the allyl group in the molecule of the active drugs.
    Abbritti G; De Matteis F
    Chem Biol Interact; 1972 Mar; 4(4):281-6. PubMed ID: 5008942
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug-induced porphyrin biosynthesis. IV. Investigation of the differences in response of isolated liver cells and the liver of the intact chick embryo to porphyria-inducing drugs.
    Racz WJ; Marks GS
    Biochem Pharmacol; 1972 Jan; 21(2):143-51. PubMed ID: 4645552
    [No Abstract]   [Full Text] [Related]  

  • 25. 17-Oxosteroid control of porphyrin biosynthesis.
    Moore MR; Paxton JW; Beattie AD; Goldberg A
    Enzyme; 1973; 16(1):314-25. PubMed ID: 4791050
    [No Abstract]   [Full Text] [Related]  

  • 26. Enzymes in the hepatic porphyrias.
    Lancet; 1972 Jul; 2(7768):121. PubMed ID: 4113898
    [No Abstract]   [Full Text] [Related]  

  • 27. The redox state of the liver in symptomatic porphyria.
    Shanley BC; Joubert SM
    S Afr Med J; 1972 Jun; 46(24):772-4. PubMed ID: 5076058
    [No Abstract]   [Full Text] [Related]  

  • 28. [On effect of fructose and glucose on content of carbohydrate metabolites and adenosine phosphates in venous blood of liver in health subjects and patients with liver cirrhosis].
    Michel D; Lamprecht W; Göldel L; Zimmermann W; Hagenloh I; Rehling M; Hungbauer E
    Hoppe Seylers Z Physiol Chem; 1965; 342(1):140-7. PubMed ID: 5875613
    [No Abstract]   [Full Text] [Related]  

  • 29. The hepatic porphyrias: pathogenesis, manifestations, and management.
    Bloomer JR
    Gastroenterology; 1976 Oct; 71(4):689-701. PubMed ID: 955357
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biosynthesis of heme: regulation; hereditary and experimental porphyrias].
    Grandchamp B; Nordmann Y
    Expos Annu Biochim Med; 1980; 34():45-80. PubMed ID: 7009205
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biochemical changes in acute experimental ethanol intoxication].
    Bondoli A; Pala F; Fava I; Camaioni D; Magalini SI
    Minerva Anestesiol; 1982 Apr; 48(4):227-32. PubMed ID: 6890176
    [No Abstract]   [Full Text] [Related]  

  • 32. The porphyrias: a review.
    Elder GH; Gray CH; Nicholson DC
    J Clin Pathol; 1972 Dec; 25(12):1013-33. PubMed ID: 4570617
    [No Abstract]   [Full Text] [Related]  

  • 33. [Exogenous inductors in the clinical manifestations of hepatic porphyria].
    Horváth T; Mándy I; Vezekényi Z; Simon K; Jávor T
    Orv Hetil; 1976 Jun; 117(24):1447-51. PubMed ID: 934636
    [No Abstract]   [Full Text] [Related]  

  • 34. [The role of endogenous inductors in the clinical symptoms of hepatic porphyria].
    Horváth T; Németh M; Juricskayné DZ; Ludány A; Pár A; Ruzsa C
    Orv Hetil; 1976 Jul; 117(28):1691-6. PubMed ID: 967408
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biochemical observations on porphyria. Studies on adenosine nucleotide metabolism in experimental porphyria].
    Motomatsu T
    Fukuoka Igaku Zasshi; 1975 Mar; 66(3):167-74. PubMed ID: 1168608
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biochemistry of porphyria].
    Uhlig HJ
    Z Arztl Fortbild (Jena); 1981 Jan; 75(1):1-4. PubMed ID: 7222767
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent advances in porphyrin metabolism.
    Pindyck J; Kappas A; Levere RD
    CRC Crit Rev Clin Lab Sci; 1971; 2(4):639-57. PubMed ID: 4944524
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental hepatic porphyria: studies with steroids of physiological origin in man.
    Kappas A; Granick S
    Ann N Y Acad Sci; 1968 Jul; 151(2):842-9. PubMed ID: 5263692
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biochemical and histomorphological changes in experimental hexachlorbenzol porphyria (author's transl)].
    Iwanow E; Hlebarowa M; Krustev L; Dimitrov P; Orbetzova V; Nenov P; Kirjakov A; Tsontscheva A
    Acta Hepatogastroenterol (Stuttg); 1973; 20(1):39-48. PubMed ID: 4357058
    [No Abstract]   [Full Text] [Related]  

  • 40. [Disturbances of metabolism in experimental porphyrias].
    Panfil B
    Postepy Hig Med Dosw; 1969; 23(3):275-91. PubMed ID: 4896416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.